shortagewatch

Home / Companies / Sanofi

Company family · HQ FR

Sanofi: medicine shortages

SAN · Euronext Paris

As of 2 Nov 2026, 158 Sanofi products have a reported shortage across 13 countries, covering 45 medicines.

Products short158rank #14 of 464
Medicines45active ingredients
Countries13/16
New in 90 days97+66 vs market pace
Typical duration46 daysmedian so far
Manufacturing68%demand-driven 11%

Where

United States38Canada15Germany25Italy25Spain14Ireland4Austria8Belgium11Switzerland1Czechia3Norway6Sweden4Japan4

Which therapeutic classes

Blood30Anti-infectives28Digestive tract and metabolism23Cardiovascular system22Systemic hormones21Nervous system14Cancer and immune system7Various4Dermatologicals2Antiparasitics1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
SanofiSanofi: Manufacturing problem 65 (42%)42%Sanofi: Increased demand 10 (6%)6%Sanofi: Distribution or logistics 3 (2%)Sanofi: Other 15 (10%)10%Sanofi: Not stated 63 (40%)40%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

When its current shortages began

0255075100Dec: 1Jan ’25: 0Feb: 0FebMar: 2Apr: 2May: 0MayJun: 3Jul: 1Aug: 0AugSep: 3Oct: 2Nov: 1NovDec: 4Jan ’26: 1Feb: 2FebMar: 4Apr: 1May: 1MayJun: 8Jul: 7Aug: 13AugSep: 14Oct: 69Nov: 1Nov

Long-run trend in Canada

Canada dashboard
02550751002017: 2720172018: 3620182019: 4520192020: 3420202021: 3820212022: 9320222023: 5720232024: 1520242025: 2120252026: 322026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Jamp151

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Sanofi: 158 / 45Sanofi

Further right: more products short. Higher: more different medicines affected.

Medicines short

MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Enoxaparin2831 Aug 2026Not stated8/16
Triamcinolone111 Oct 2026Manufacturing problem8/16
Avalglucosidase Alfa1018 Mar 2025Manufacturing problem8/16
Valproic Acid1026 Jun 2025Manufacturing problem10/16
Influenza, Inactivated, Split Virus Or Surface Antigen87 Aug 2026Not stated4/16
Alirocumab54 Oct 2026Manufacturing problem4/16
Adenosine423 Dec 2025Distribution or logistics5/16
Furosemide410 Feb 2026Manufacturing problem11/16
Insulin Lispro41 Sep 2025Manufacturing problem3/16
Rifampicin45 Aug 2021Manufacturing problem8/16
Amisulpride37 Sep 2026Increased demand5/16
Doxercalciferol310 Dec 2025Not stated1/16
Leflunomide38 Jun 2026Not stated3/16
Rabies, Inactivated, Whole Virus34 Sep 2026Increased demand4/16
Sevelamer310 Aug 2026Manufacturing problem5/16
Alglucosidase Alfa230 Jul 2026Manufacturing problem2/16
Clopidogrel223 Oct 2026Not stated9/16
Dronedarone24 Sep 2026Not stated3/16
Insulin Aspart23 Sep 2026Other6/16
Insulin Glargine231 Aug 2026Other6/16
Irbesartan and Diuretics25 Oct 2026Other4/16
Leflunomide28 Jun 2026Not stated1/16
Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated21 Oct 2026Not stated3/16
Metolazone226 Oct 2026Not stated1/16
Olipudase Alfa210 Jul 2026Manufacturing problem3/16
Pertussis, Purified Antigen, Combinations with Toxoids24 Oct 2024Other3/16
Rifampicin and Isoniazid216 Aug 2021Manufacturing problem6/16
Teicoplanin212 Jun 2024Manufacturing problem5/16
Amiodarone123 Sep 2026Not stated5/16
Colestyramine11 Sep 2026Quality problem or recall6/16
Cromoglicic Acid112 Sep 2025Manufacturing problem1/16
Diltiazem112 Nov 2026Increased demand7/16
Diphtheria-Pertussis-Poliomyelitis-Tetanus115 Oct 2024Other4/16
Docetaxel1not givenNot stated8/16
Haemophilus Influenzae B, Purified Antigen Conjugated11 Sep 2026Not stated1/16
Hydroxychloroquine1not givenNot stated3/16
Insulin Lispro126 Jan 2026Other1/16
Liothyronine Sodium12 Dec 2024Other3/16
Minocycline115 Jul 2025Manufacturing problem3/16
Podophyllotoxin1not givenNot stated2/16
Poliomyelitis, Trivalent, Inactivated, Whole Virus124 Nov 2025Not stated1/16
Polystyrene Sulfonate126 Oct 2026Manufacturing problem3/16
Teriflunomide110 Sep 2026Increased demand4/16
Tetanus Toxoid114 Apr 2025Manufacturing problem1/16
Zopiclone1not givenNot stated3/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.